Page last updated: 2024-10-30

lobenzarit and Acquired Nephrogenic Diabetes Insipidus

lobenzarit has been researched along with Acquired Nephrogenic Diabetes Insipidus in 1 studies

lobenzarit: prevents autoimmune kidney disease in hybrid mice; RN given refers to parent cpd

Research Excerpts

ExcerptRelevanceReference
"Nephrogenic diabetes insipidus (NDI) occurred in a 43-year-old woman who had received lobenzarit disodium for the treatment of rheumatoid arthritis (RA)."8.79Nephrogenic diabetes insipidus induced by lobenzarit disodium treatment in patients with rheumatoid arthritis. ( Kondo, M; Miyazaki, R; Sakane, N; Umekawa, T; Yoshida, T, 1996)
"Nephrogenic diabetes insipidus (NDI) occurred in a 43-year-old woman who had received lobenzarit disodium for the treatment of rheumatoid arthritis (RA)."4.79Nephrogenic diabetes insipidus induced by lobenzarit disodium treatment in patients with rheumatoid arthritis. ( Kondo, M; Miyazaki, R; Sakane, N; Umekawa, T; Yoshida, T, 1996)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sakane, N1
Yoshida, T1
Umekawa, T1
Miyazaki, R1
Kondo, M1

Reviews

1 review available for lobenzarit and Acquired Nephrogenic Diabetes Insipidus

ArticleYear
Nephrogenic diabetes insipidus induced by lobenzarit disodium treatment in patients with rheumatoid arthritis.
    Internal medicine (Tokyo, Japan), 1996, Volume: 35, Issue:2

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Diabetes Insipidus, Nephrogen

1996